JPY 772.0
(-0.39%)
Breakdown | 2023 | 2022 | 2021 |
---|---|---|---|
Operating Cash Flow | 49.22 Million | 146.27 Million | 86.2 Million |
Net Income | 112.59 Million | 110.17 Million | 49.72 Million |
Depreciation & Amortization | 4.65 Million | 7.31 Million | 7.56 Million |
Deferred income taxes | - | - | - |
Stock-based compensation | - | - | - |
Change in working capital | -37.59 Million | 54.82 Million | -22.64 Million |
Other non-cash items | 26.49 Million | 2.9 Million | -4.54 Million |
Investing Cash Flow | -5.18 Million | -7.86 Million | -14.35 Million |
Investments in PPE | -767 Thousand | -3.57 Million | -9.6 Million |
Acquisitions | - | - | - |
Investment purchases | -119 Thousand | -88 Thousand | - |
Sales/Maturities of investments | - | 100 Thousand | - |
Other Investing Activities | -4.29 Million | -4.3 Million | -4.74 Million |
Financing Cash Flow | 432.53 Million | -122.4 Million | -149.93 Million |
Debt repayment | -97.16 Million | -122.4 Million | -149.93 Million |
Dividends payments | - | - | - |
Common Stock Repurchased | -3.2 Million | - | - |
Common Stock Issuance | 537.98 Million | - | - |
Other Financing Activities | -2000.00 | - | - |
Accounts receivables | -56.82 Million | - | - |
Accounts payables | - | - | - |
Inventory | 39.62 Million | -26.56 Million | 39.18 Million |
Other working capital | -20.39 Million | - | - |
Cash at beginning of period | 600.63 Million | 584.63 Million | 662.71 Million |
Cash at end of period | 1.07 Billion | 600.63 Million | 584.63 Million |
Capital Expenditure | -767 Thousand | -3.57 Million | -9.6 Million |
Effect of forex changes on cash | - | - | - |
Net cash flow / Change in cash | 476.57 Million | 16 Million | -78.07 Million |
Free Cash Flow | 48.45 Million | 142.69 Million | 76.6 Million |
Breakdown | 2023 FY | 2022 FY | 2021 FY |
---|---|---|---|
Operating Cash Flow | - | - | - |
Net Income | 112.59 Million | 110.17 Million | 49.72 Million |
Depreciation & Amortization | 4.65 Million | 7.31 Million | 7.56 Million |
Deferred income taxes | - | - | - |
Stock-based compensation | - | - | - |
Change in working capital | -37.59 Million | 54.82 Million | -22.64 Million |
Other non-cash items | 26.49 Million | 2.9 Million | -4.54 Million |
Investing Cash Flow | -5.18 Million | -7.86 Million | -14.35 Million |
Investments in PPE | -767 Thousand | -3.57 Million | -9.6 Million |
Acquisitions | - | - | - |
Investment purchases | -119 Thousand | -88 Thousand | - |
Sales/Maturities of investments | - | 100 Thousand | - |
Other Investing Activities | -4.29 Million | -4.3 Million | -4.74 Million |
Financing Cash Flow | 432.53 Million | -122.4 Million | -149.93 Million |
Debt repayment | -97.16 Million | -122.4 Million | -149.93 Million |
Dividends payments | - | - | - |
Common Stock Repurchased | -3.2 Million | - | - |
Common Stock Issuance | 537.98 Million | - | - |
Other Financing Activities | -2000.00 | - | - |
Accounts receivables | - | - | - |
Accounts payables | - | - | - |
Inventory | 39.62 Million | -26.56 Million | 39.18 Million |
Other working capital | - | - | - |
Cash at beginning of period | 600.63 Million | 584.63 Million | 662.71 Million |
Cash at end of period | 1.07 Billion | 600.63 Million | 584.63 Million |
Capital Expenditure | -767 Thousand | -3.57 Million | -9.6 Million |
Effect of forex changes on cash | - | - | - |
Net cash flow / Change in cash | 476.57 Million | 16 Million | -78.07 Million |
Free Cash Flow | 48.45 Million | 142.69 Million | 76.6 Million |
000564
EKAD
LEMONTREE
R3NK
CLEDUCATE
UD2